Company: BIAF
Filing Date: 2025-08-29
Form Type: S-1
Source: 0001641172-25-025990
Chunk: 22

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-29
Form: S-1
Chunk 22
---
,173 shares of Common Stock issuable upon conversion of 150 Series B Preferred          
 Stock and (ii) 1,017,391 shares of Common Stock issuable upon exercise of Private Warrants. The shares listed in the second column          
 consist of the aforementioned shares and 3,377,905 shares of Common Stock issuable upon exercise of common stock purchase warrants.         
 Michael Bigger is the managing member of District 2 Capital Fund LP and has voting control and investment discretion over securities        
 beneficially owned directly by District 2 Capital Fund LP. In such roles, Mr. Bigger may be deemed to beneficially own the securities       
 owned by District 2 Capital Fund LP. We have been advised that none of Mr. Bigger or District 2 Capital Fund LP is a member of the          
 Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, an affiliate or associated person of a FINRA            
 member, or an affiliate of a broker-dealer. The foregoing should not be construed in and of itself as an admission by Mr. Bigger            
 as to beneficial ownership of the securities beneficially owned directly by District 2 Capital Fund LP. The business address of District    
 2 Capital Fund LP is 14 Wall Street, 2nd Floor, Huntington NY 11743.                                                                        |
| (10) | The                                                                                                                                         
 shares listed in the third column consist of (i) 217,391 shares of Common Stock issuable upon conversion of 50 Series B Preferred           
 Stock and (ii) 339,130 shares of Common Stock issuable upon exercise of Private Warrants. The shares listed in the second column            
 consist of the aforementioned shares and 703,125 shares of Common Stock issuable upon exercise of common stock purchase warrants            
 owned by Warberg WF XII LP. Daniel Warsh is the principal of the general partner of Warberg WF XII LP and has voting control and            
 investment discretion over securities beneficially owned directly by Warberg WF XIII LP. In such roles, Mr. Warsh may be deemed to          
 beneficially own the securities owned by Warberg WF XIII LP. We have been advised that none of Mr. Warsh, Warberg XII LP or Warberg         
 WF XIII LP is a member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, an affiliate or           
 associated person of a FINRA member, or an affiliate of a broker-dealer. The foregoing should not be construed in and of itself as          
 an admission by Mr